Long-Term Maternal and Offspring Adverse Effects of Gestational Diabetes Mellitus
- 1Department of Obstetrics & Gynecology and Reproductive Medicine, Peking University First Hospital, Beijing 100034, China
- 2Department of Medicine, Melrose Wakefield Hospital, Melrose, Massachusetts 02176, United States of America
Abstract
Gestational diabetes mellitus (GDM) serves as a diagnostic “stress test” for maternal physiology, exposing underlying metabolic vulnerabilities that imply a potential lifelong cardiometabolic trajectory for both mother and offspring. Mothers with a history of GDM face a 6-to-10-fold increased risk of developing type 2 diabetes mellitus and a 1.4-to-2.0-fold higher risk of cardiovascular disease, chronic hypertension, and chronic kidney disease. These risks are further compounded by factors such as obesity, hypertension, or adverse postpartum weight gain. For offspring, in utero exposure to hyperglycemia is thought to contribute to developmental programming that increases obesity risk—rising from approximately 1.1-fold in early childhood to 2.0-fold by adolescence—and predisposes them to early-onset dysglycemia. Although modest associations between in utero GDM exposure and both neurodevelopmental disorders and early cardiovascular events have been documented, these outcomes appear highly dependent on the postnatal environment. Despite the heterogeneity in findings among observational studies and variations in GDM diagnostic criteria, GDM should be regarded as a critical marker of long-term intergenerational risk for these adverse cardiometabolic and developmental outcomes. This review advocates for a clinical paradigm shift, positioning GDM as a sentinel event that requires a transition from episodic pregnancy care toward sustained, life-course cardiometabolic surveillance and preventative strategies for both mother and offspring.
Related
- Maternal serum retinol, vitamin K, and ferritin profiles during pregnancy, gestational diabetes mellitus, and offspring neurodevelopment: a prospective case-control study
- Association of third-trimester maternal lipid levels with adverse pregnancy outcomes in women with gestational diabetes mellitus: a retrospective single-center study using intrapartum data
- A risk assessment model for gestational diabetes mellitus integrating maternal demographics and hematological indices in Thai women.
- Temporal patterns and adverse pregnancy outcomes of hypertensive disorders of pregnancy and gestational diabetes mellitus in Hebei Province, China, 2017–2023: a multicenter retrospective cohort study
- Bump2Baby & Me+ (B2B&Me+): Protocol for a multi-country, European hybrid type 3 implementation-effectiveness study to reduce the incidence of gestational diabetes mellitus and improve maternal and child health
BibTeX
@article{juan2026longterm,
title = {{Long-Term Maternal and Offspring Adverse Effects of Gestational Diabetes Mellitus}},
author = {Juan Juan and Zongyuan Tian and Yurong Lu and Chong Shou and Huixia Yang},
journal = {Maternal-fetal medicine (Wolters Kluwer Health, Inc.)},
year = {2026},
month = jun,
doi = {10.1097/fm9.0000000000000361},
url = {https://europepmc.org/article/PMC/PMC13706459},
note = {CC BY-NC-ND},
}
RIS
TY - JOUR
TI - Long-Term Maternal and Offspring Adverse Effects of Gestational Diabetes Mellitus
AU - Juan Juan
AU - Zongyuan Tian
AU - Yurong Lu
AU - Chong Shou
AU - Huixia Yang
PY - 2026
DA - 2026/06/08
JO - Maternal-fetal medicine (Wolters Kluwer Health, Inc.)
DO - 10.1097/fm9.0000000000000361
UR - https://europepmc.org/article/PMC/PMC13706459
AB - Gestational diabetes mellitus (GDM) serves as a diagnostic “stress test” for maternal physiology, exposing underlying metabolic vulnerabilities that imply a potential lifelong cardiometabolic trajectory for both mother and offspring. Mothers with a history of GDM face a 6-to-10-fold increased risk of developing type 2 diabetes mellitus and a 1.4-to-2.0-fold higher risk of cardiovascular disease, chronic hypertension, and chronic kidney disease. These risks are further compounded by factors such as obesity, hypertension, or adverse postpartum weight gain. For offspring, in utero exposure to hyperglycemia is thought to contribute to developmental programming that increases obesity risk—rising from approximately 1.1-fold in early childhood to 2.0-fold by adolescence—and predisposes them to early-onset dysglycemia. Although modest associations between in utero GDM exposure and both neurodevelopmental disorders and early cardiovascular events have been documented, these outcomes appear highly dependent on the postnatal environment. Despite the heterogeneity in findings among observational studies and variations in GDM diagnostic criteria, GDM should be regarded as a critical marker of long-term intergenerational risk for these adverse cardiometabolic and developmental outcomes. This review advocates for a clinical paradigm shift, positioning GDM as a sentinel event that requires a transition from episodic pregnancy care toward sustained, life-course cardiometabolic surveillance and preventative strategies for both mother and offspring.
SN - 2096-6954
SN - 2641-5895
ER -